Inventor

BRAFORD-GOLDBERG SARAH RUTH

US26 patents

⚠️ This page may combine multiple inventors who share the name “BRAFORD-GOLDBERG SARAH RUTH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRAFORD-GOLDBERG SARAH RUTH

SEARLE & CO

Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides

Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors

Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines

Therapeutic methods using fusion proteins between interleukin-3 (IL-3) variants and other hematopoietic factors

Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins

Co-administration of interleukin-3 mutant polypeptides with CSF&#39;s for multi-lineage hematopoietic cell production

Multivariant human IL-3 fusion proteins and their recombinant production

Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors

Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them

Treatment of hematopoietic disorders with fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors

Recombinant human interleukin-3 (IL-3) multiple mutation polypeptides

Interleukin-3 (IL-3) mutant polypeptides and their recombinant production

G-CSF receptor agonists

Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins

Co-administration of interleukin-3 mutant polypeptides with CSF&#39;s or cytokines for multi-lineage hematopoietic cell production

Human interleukin-3 (IL-3) variant fusion proteins

Co-administration of interleukin-3 mutant polypeptides with CSF&#39;s for multi-lineage hematopoietic cell production

Therapeutic uses of interleukin-3 (IL-3) multiple mutation polypeptides

Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides

Co-administration of interleukin-3 mutants with colony stimulating factors

(unassigned)

Methods of using multivariant IL-3 hematopoiesis fusion protein

Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors

Co-administration of interleukin-3 mutant polypeptides with CSF&#39;S for multi-lineage hematopoietic cell production

Compositions for increasing hematopoiesis with interleukin-3 mutants

PHARMACIA CORP

Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells

BAUER S CHRISTOPHER

IL-3 variant hematopoiesis fusion protein

Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production

Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production

Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production

Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production